Desktop Site |
25 Jun 18 | 11:39 | Open
Equity SME Derivatives Currency Corporates
Get Quote  
Notices |
S&P BSE SENSEX 35,627.22 -62.38 -0.17 %
Corporate Announcement
  • Security Code500124
    CompanyDR.REDDY'S LABORATORIES LTD.
    Exchange Disseminated Time
     
     
     Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-oncology and Precision Oncology Targets | 1/22/2015 3:46:15 PM 
     Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated January 21, 2015, titled "Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-oncology and Precision Oncology Targets". 
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(10H) 25 Jun 18|11:39 (IST)